In this review we would like to summarize our current knowledge on the biogenesis of mammalian peroxisomes and discuss in detail single steps which led to the current model of peroxisome biogenesis. Since some recent results obviously are not fully compatible with this model a revised version is dis
Pharmacological induction of peroxisomes in peroxisome biogenesis disorders
β Scribed by Heming Wei; Stephan Kemp; Martina C. McGuinness; Ann B. Moser; Kirby D. Smith
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 727 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Ξ±βSynuclein (Ξ±S) is a presynaptic protein implicated in Parkinson's disease (PD). Growing evidence implicates mitochondrial dysfunction, oxidative stress, and Ξ±Sβlipid interactions in the gradual accumulation of Ξ±S in pathogenic forms and its deposition in Lewy bodies, the pathological
The peroxisome biogenesis disorders (PBD) are characterized by neural, hepatic, and renal deficiencies, severe mental retardation, and are often lethal. These disorders are genetically and phenotypically heterogeneous and are caused by defective peroxisomal protein import and decreased peroxisomal m
Diseases of the Zellweger spectrum represent a major subgroup of the peroxisome biogenesis disorders, a group of autosomal-recessive diseases that are characterized by widespread tissue pathology, including neurodegeneration. The Zellweger spectrum represents a clinical continuum, with Zellweger syn
Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas, 1 and 65% of non-Hispanic American families have been linked to CCM1 with no founder effects. 2 The common mutation, 742C3 T transition, recently described in 16 of 21 families, 3 supports the previously described str